The company provides an end-to-end solution for RNA sequencing that includes shorter turn-around times from RNA to library prep, complete data analysis, and lower cost per sample compared to whole transcriptome sequencing approaches for RNASeq. Amaryllis Nucleics' technology is designed to break down the barriers of time and cost, empowering researchers and accelerating important discoveries in genomics, including cancer diagnostics, pharmaceutical development, and food security.